In 2011, HeLa cells were used in tests of novel heptamethine dyes IR-808 and other analogs which are currently being explored for their unique uses in medical diagnostics, the development of theranostics, the individualized treatment of cancer patients with the aid of PDT, co-administration with other drugs, and irradiation.
En 2011, as células HeLa usáronse nas probas das novas tinguiduras heptametino IR-808 e outros análogos que están actualmente sendo examinados para o seu uso en diagnose médica, o desenvolvemento de teranósticos (diagnósticos e tratamentos personalizados), o tratamento individualizado de pacientes cancerosos coa axuda de terapia fotodinámica (PDT), coadministración con outras drogas, e irradiación.